Future directions in the management of tertiary peritonitis

[1]  D. Zandstra,et al.  The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients , 2004, Intensive Care Medicine.

[2]  C. van der Werken,et al.  Surgical management of severe secondary peritonitis. , 1999, The British journal of surgery.

[3]  G. Van den Berghe,et al.  Increased mortality associated with growth hormone treatment in critically ill adults. , 2000, The New England journal of medicine.

[4]  R. Demling.  Growth hormone therapy in critically ill patients. , 1999, The New England journal of medicine.

[5]  M. Haller,et al.  Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. , 1999, Critical care medicine.

[6]  A. Vinks,et al.  Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis. , 1999, Therapeutic drug monitoring.

[7]  D. Wittmann.  Operative and nonoperative therapy of intraabdominal infections , 1998, Infection.

[8]  H. Saito.  Anabolic agents in trauma and sepsis: repleting body mass and function. , 1998, Nutrition.

[9]  J. Marshall,et al.  Tertiary Peritonitis: Clinical Features of a Complex Nosocomial Infection , 1993, World Journal of Surgery.

[10]  H. Volk,et al.  Immunstimulation durch G-CSF (Neupogen®) bei septischen Patienten mit Immunparalyse , 1998 .

[11]  K. Ilett,et al.  Pharmacokinetics of Drugs Used in Critically Ill Adults , 1998, Clinical pharmacokinetics.

[12]  W. Craig,et al.  Pharmacokinetic/pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men Tions Were Associated with Only a Slight Reduction in Bacterial , 2022 .

[13]  H. Bruining,et al.  Corticosteroid therapy in severe illness. , 1997, The New England journal of medicine.

[14]  M. Heslin,et al.  A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. , 1997, Annals of surgery.

[15]  C. Pichard,et al.  Growth hormone therapy in intensive care patients: from biochemistry to muscle function. , 1997, Nutrition.

[16]  R. Bone,et al.  Sepsis: a new hypothesis for pathogenesis of the disease process. , 1997, Chest.

[17]  D. Pittet,et al.  The changing epidemiology of severe infections in the ICU , 1997 .

[18]  G. Parmigiani,et al.  The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  E. Roth,et al.  Does reoperation for abdominal sepsis enhance the inflammatory host response? , 1997, Archives of surgery.

[20]  H. Allgayer,et al.  MODULATION OF IMMUNE RESPONSE BY BLOOD TRANSFUSION: EVIDENCE FOR A DIFFERENTIAL EFFECT OF ALLOGENEIC AND AUTOLOGOUS BLOOD IN COLORECTAL CANCER SURGERY , 1995, Shock.

[21]  K. Asadullah,et al.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.

[22]  H. van Goor,et al.  Complications of planned relaparotomy in patients with severe general peritonitis. , 1997, The European journal of surgery = Acta chirurgica.

[23]  S. V. van Deventer,et al.  Is G-CSF safe and useful in the treatment of infectious diseases in the non-neutropenic host? , 1997, Intensive Care Medicine.

[24]  R. Ross,et al.  Growth hormone therapy for protein catabolism. , 1996, QJM : monthly journal of the Association of Physicians.

[25]  M. Schein,et al.  Hypothesis: compartmentalization of cytokines in intraabdominal infection. , 1996, Surgery.

[26]  M. Heinzelmann,et al.  SEPSIS AND SEPTIC COMPLICATIONS IN THE SURGICAL PATIENT: WHO IS AT RISK? , 1996, Shock.

[27]  K. Kudsk,et al.  Loss of upper respiratory tract immunity with parenteral feeding. , 1996, Annals of surgery.

[28]  E. Deitch,et al.  Role of the Gut in Multiple Organ Failure: Bacterial Translocation and Permeability Changes , 1996, World Journal of Surgery.

[29]  Goris Rj,et al.  SIRS, MODS and tertiary peritonitis. , 1996 .

[30]  M. Schein,et al.  Duration of antibiotic treatment in surgical infections of the abdomen. Forum statement: a plea for selective and controlled postoperative antibiotic administration. , 1996, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[31]  R. Goris,et al.  SIRS, MODS and tertiary peritonitis. , 1996, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[32]  K. Asadullah,et al.  Very low monocytic HLA-DR expression indicates high risk of infection--immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. , 1995, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[33]  J. Lange,et al.  Controlled Clinical Trial of Selective Decontamination for the Treatment of Severe Acute Pancreatitis , 1995, Annals of surgery.

[34]  K. Kudsk,et al.  Is early feeding beneficial? How early is early? , 1994, New horizons.

[35]  R. Hetzer,et al.  Monitoring of the cellular immune system in patients with biventricular assist devices awaiting cardiac transplantation. , 1994, Clinical transplantation.

[36]  K. Kudsk.  Gut mucosal nutritional support--enteral nutrition as primary therapy after multiple system trauma. , 1994, Gut.

[37]  Nathens Ab,et al.  Nosocomial infection in the surgical intensive care unit. , 1992 .

[38]  A. Hirshberg,et al.  Current surgical management of severe intraabdominal infection. , 1992, Surgery.

[39]  E. Moore,et al.  Early Enteral Feeding, Compared With Parenteral, Reduces Postoperative Septic Complications The Results of a Meta‐Analysis , 1992, Annals of surgery.

[40]  H. Bruining,et al.  Role of selective decontamination in surgery , 1992, The British journal of surgery.

[41]  F. Cerra,et al.  Multiple organ failure syndrome. , 1990, Disease-a-month : DM.

[42]  J. Marshall,et al.  Nosocomial infection in the surgical intensive care unit. , 1992, Infectious disease clinics of North America.

[43]  M. Schein.  Planned reoperations and open management in critical intra-abdominal infections: Prospective experience in 52 cases , 1991, World journal of surgery.

[44]  J. Solomkin,et al.  Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. , 1990, Annals of surgery.

[45]  H. Polk,et al.  Monocyte HLA‐DR antigen expression characterizes clinical outcome in the trauma patient , 1990, The British journal of surgery.

[46]  J. Marshall,et al.  Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. , 1990, Archives of surgery.

[47]  R. Douglas,et al.  Metabolic response to sepsis and trauma , 1989, The British journal of surgery.

[48]  H. Briedigkeit,et al.  Diagnostic value of an immune monitoring program for the clinical management of immunosuppressed patients with septic complications , 1989 .

[49]  R. Simmons,et al.  Microbiologic features and treatment of persistent peritonitis in patients in the intensive care unit. , 1986, Canadian journal of surgery. Journal canadien de chirurgie.

[50]  J. Lundy,et al.  Surgery, trauma and immune suppression. Evolving the mechanism. , 1983, Annals of surgery.